GW Pharmaceuticals plans to recruit approximately 116 children with Lennox-Gastaut Syndrome to participate in a new clinical trial. The study … More
Most recent patent granted on Oct. 24, 2019 Over the past two decades, GW Pharmaceuticals (GWPH) has been granted multiple … More
When paired with certain antibiotics, CBD significantly enhanced antibacterial effects.
Four new studies on CBD and clobazam have conflicting results.
The approval of EPIDYOLEX® marks a significant milestone, offering patients and their families the first in a new class of epilepsy medicines and the first and only EMA-approved CBD medicine to treat two severe and life-threatening forms of childhood-onset epilepsy.”
Provides the first real world data (outside a clinical trial) on the dosing of THC:CBD in amyotrophic lateral sclerosis (ALS).
Some bacterial infections are becoming resistant to antibiotics. It turns out that CBD may be effective in the fight against dangerous infections.